Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen M L Oh

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Infectious Diseases|April 25, 2007
Melioidosis complicated by pericarditisKieron B L Lim, Helen M L Oh
Vaccines|January 24, 2025
Reflections on COVID-19: A Literature Review of SARS-CoV-2 TestingChin Shern Lau, Helen M L Oh, Tar Choon Aw
Annals of the Academy of Medicine, Singapore|July 14, 2010
Evaluation of intensive care unit-acquired urinary tract infections in SingaporeMindy K X Tay, Joyce Y C Lee, Ian Y J Wee, et al.
Emerging Infectious Diseases|March 20, 2004
Atypical SARS in geriatric patientAugustine K H Tee, Helen M L Oh, Christopher T C Lien, et al.
Plos One|November 27, 2013
Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control studyTun-Linn Thein, Yee-Sin Leo, Dale A Fisher, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2013
Clinico-genetic characterisation of an encephalitic Dengue virus 4 associated with multi-organ involvementHapuarachchige C Hapuarachchi, Helen M L Oh, Tun Linn Thein, et al.
Vaccine|November 28, 2017
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimenShirin Kalimuddin, Limin Wijaya, Yvonne F Z Chan, et al.
The Journal of Infectious Diseases|December 26, 2015
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 StudyChukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera, et al.
The New England Journal of Medicine|June 14, 2008
A clinical trial of a whole-virus H5N1 vaccine derived from cell cultureHartmut J Ehrlich, Markus Müller, Helen M L Oh, et al.
Vaccine|November 15, 2011
Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccinePaul A Tambyah, Annelies Wilder-Smith, Borislava G Pavlova, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Infectious Diseases|April 25, 2007
Melioidosis complicated by pericarditisKieron B L Lim, Helen M L Oh
Vaccines|January 24, 2025
Reflections on COVID-19: A Literature Review of SARS-CoV-2 TestingChin Shern Lau, Helen M L Oh, Tar Choon Aw
Annals of the Academy of Medicine, Singapore|July 14, 2010
Evaluation of intensive care unit-acquired urinary tract infections in SingaporeMindy K X Tay, Joyce Y C Lee, Ian Y J Wee, et al.
Emerging Infectious Diseases|March 20, 2004
Atypical SARS in geriatric patientAugustine K H Tee, Helen M L Oh, Christopher T C Lien, et al.
Plos One|November 27, 2013
Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control studyTun-Linn Thein, Yee-Sin Leo, Dale A Fisher, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2013
Clinico-genetic characterisation of an encephalitic Dengue virus 4 associated with multi-organ involvementHapuarachchige C Hapuarachchi, Helen M L Oh, Tun Linn Thein, et al.
Vaccine|November 28, 2017
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimenShirin Kalimuddin, Limin Wijaya, Yvonne F Z Chan, et al.
The Journal of Infectious Diseases|December 26, 2015
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 StudyChukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera, et al.
The New England Journal of Medicine|June 14, 2008
A clinical trial of a whole-virus H5N1 vaccine derived from cell cultureHartmut J Ehrlich, Markus Müller, Helen M L Oh, et al.
Vaccine|November 15, 2011
Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccinePaul A Tambyah, Annelies Wilder-Smith, Borislava G Pavlova, et al.
Pageof 2